BPC-157 and the Regulatory Rules By Mussarat Fatima Peptides have moved from bodybuilding forums into mainstream wellness marketing
Nausea 16-46%, diarrhea 16-26%, vomiting 8-22%
Important safety considerations: Patients should contact their GP if they experience severe injection site reactions, signs of infection (fever, spreading erythema), chest pain, palpitations, or allergic symptoms
Usage in Pregnancy Since adequate human reproduction studies have not been done with corticosteroids, use of these drugs in pregnancy, nursing mothers or women of childbearing potential requires that the possible benefits of the drug be weighed against the potential hazards to the mother and embryo or fetus
Gut 72 (2), 338344
Combining the unique properties of BPC-157 and TB-500, this product is designed to support advanced scientific studies in controlled laboratory settings